Insights

Sustainable feedstock Yield10 focuses on Camelina sativa as a platform crop for low-carbon feedstock oils used in renewable diesel and sustainable aviation biofuels, presenting a sales opportunity with energy and chemical refineries seeking decarbonized feedstocks.

Omega-3 expansion The company is developing omega-3 oils (EPA and DHA) from engineered Camelina for pharmaceutical, nutraceutical, and aquafeed applications, offering cross-vertical sell opportunities to pharma suppliers, supplement manufacturers, and aquaculture feed producers.

Strategic partnerships Recent and ongoing partnerships, including licenses with Vision Bioenergy Oilseeds and collaboration prospects with Nufarm, indicate a channel strategy potential for distributing seed varieties and biofuel feedstock, enabling co-sales with agribusiness and agri-chemical companies.

Regulatory momentum USDA BRS authorization for growing and breeding omega-3 Camelina varieties signals regulatory progress that can de-risk customer pilots and field programs, enabling faster go-to-market and proof-of-concept deployments for customers evaluating biobased inputs.

Early-stage monetization With revenue in the low single-digit millions and a lean team, there are opportunities to pursue pilot contracts, grain contracting for low-carbon oil, and limited-scope seed sales to agribusiness buyers seeking sustainable feedstock and specialty oils.

Similar companies to Yield10 Bioscience

Yield10 Bioscience Tech Stack

Yield10 Bioscience uses 8 technology products and services including CookieScript, Amazon ALB, Google Maps, and more. Explore Yield10 Bioscience's tech stack below.

  • CookieScript
    Cookie Compliance
  • Amazon ALB
    Load Balancers
  • Google Maps
    Maps
  • Microsoft
    Miscellaneous
  • JavaScript
    Programming Languages
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Nginx
    Web Servers

Media & News

Yield10 Bioscience's Email Address Formats

Yield10 Bioscience uses at least 2 format(s):
Yield10 Bioscience Email FormatsExamplePercentage
FLast@metabolix.comJDoe@metabolix.com
70%
Last@metabolix.comDoe@metabolix.com
26%
LFirst@metabolix.comDJohn@metabolix.com
4%
FLast@yield10bio.comJDoe@yield10bio.com
84%
Last@yield10bio.comDoe@yield10bio.com
16%

Frequently Asked Questions

What is Yield10 Bioscience's phone number?

Minus sign iconPlus sign icon
You can contact Yield10 Bioscience's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Yield10 Bioscience's stock symbol?

Minus sign iconPlus sign icon
Yield10 Bioscience is a publicly traded company; the company's stock symbol is YTEN.

What is Yield10 Bioscience's official website and social media links?

Minus sign iconPlus sign icon
Yield10 Bioscience's official website is yield10bio.com and has social profiles on LinkedInCrunchbase.

What is Yield10 Bioscience's SIC code NAICS code?

Minus sign iconPlus sign icon
Yield10 Bioscience's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Yield10 Bioscience have currently?

Minus sign iconPlus sign icon
As of July 2026, Yield10 Bioscience has approximately 29 employees across 1 continents, including North America. Key team members include Chief Accounting Officer: C. H.Director: R. H.Director: S. B.. Explore Yield10 Bioscience's employee directory with LeadIQ.

What industry does Yield10 Bioscience belong to?

Minus sign iconPlus sign icon
Yield10 Bioscience operates in the Biotechnology Research industry.

What technology does Yield10 Bioscience use?

Minus sign iconPlus sign icon
Yield10 Bioscience's tech stack includes CookieScriptAmazon ALBGoogle MapsMicrosoftJavaScriptYoast SEOX-XSS-ProtectionNginx.

What is Yield10 Bioscience's email format?

Minus sign iconPlus sign icon
Yield10 Bioscience's email format typically follows the pattern of FLast@metabolix.com. Find more Yield10 Bioscience email formats with LeadIQ.

How much funding has Yield10 Bioscience raised to date?

Minus sign iconPlus sign icon
As of July 2026, Yield10 Bioscience has raised $125M in funding. The last funding round occurred on Aug 11, 2023 for $3.7M.

When was Yield10 Bioscience founded?

Minus sign iconPlus sign icon
Yield10 Bioscience was founded in 2015.
Yield10 Bioscience logo

Yield10 Bioscience

Biotechnology ResearchMassachusetts, United States11-50 Employees

Yield10 Bioscience is an agricultural biotechnology company that applies advanced genetics to develop Camelina sativa as a versatile crop for producing sustainable seed-based products at scale. Its product portfolio targets feedstock oils for renewable fuels, oils rich in omega-3s for pharma, nutraceuticals, and aquaculture, and, in the longer term, bioplastics. The company plans to establish a grain contracting business anchored by high-performing Camelina seed varieties to meet demand for low-carbon oil and omega-3 ingredients. Headquartered in Woburn, Massachusetts, Yield10 also maintains a Canadian subsidiary in Saskatoon.

Yield10 is listed on Nasdaq under the ticker YTEN. It operates in the biotechnology research sector and focuses on breeding strategies to enable oilseed crops to supply targeted markets. A notable development in 2024 was approval by the U.S. Department of Agriculture for growing and breeding Yield10’s omega-3 Camelina varieties.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
YTEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $125M

    Yield10 Bioscience has raised a total of $125M of funding over 8 rounds. Their latest funding round was raised on Aug 11, 2023 in the amount of $3.7Mas a post_ipo_equity.

  • $10M$25M

    Yield10 Bioscience's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $125M

    Yield10 Bioscience has raised a total of $125M of funding over 8 rounds. Their latest funding round was raised on Aug 11, 2023 in the amount of $3.7Mas a post_ipo_equity.

  • $10M$25M

    Yield10 Bioscience's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.